Related Experiment Video

Updated: Oct 30, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.6K

Regulatory miRNA-mRNA Networks in Parkinson's Disease

Bruno Lopes Santos-Lobato1,2, Amanda Ferreira Vidal2,3,4, Ândrea Ribeiro-Dos-Santos2,4

  • 1Laboratório de Neuropatologia Experimental, Universidade Federal do Pará, Belém 66073-000, PA, Brazil.

Cells
|July 2, 2021
PubMed

Insights

This study reveals key microRNAs and genes involved in Parkinson's disease brain neurodegeneration. These findings highlight neuronal survival pathways as potential targets for new Parkinson's disease therapies.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Parkinson's disease (PD) is the second leading neurodegenerative disorder.
  • Its pathology involves alpha-synuclein, oxidative stress, mitochondrial issues, and neuroinflammation.
  • MicroRNAs (miRNAs) are known to be dysregulated in PD patients' brains, plasma, and cerebrospinal fluid.

Purpose of the Study:

  • To perform a regulatory network analysis of differentially expressed miRNAs in the brain of Parkinson's disease patients.
  • To identify specific miRNAs and their target genes implicated in PD pathophysiology.
  • To explore the role of these regulatory networks in neuronal survival and disease progression.

Main Methods:

  • Systematic review focusing on miRNA expression in the substantia nigra and putamen of PD patients.
  • Identification of differentially expressed miRNAs and their predicted target genes.
  • Functional enrichment analysis to identify related signaling pathways.

Main Results:

  • Identified 99 differentially expressed miRNAs in the PD brain, regulating 135 target genes.
  • Found five key neuronal survival genes (BCL2, CCND1, FOXO3, MYC, SIRT1) modulated by dysregulated miRNAs in the substantia nigra and putamen.
  • Functional analysis linked FoxO and PI3K-AKT signaling pathways to Parkinson's disease.

Conclusions:

  • miRNA-mRNA regulatory networks in the PD brain are crucial for disease mechanisms.
  • Neuronal survival pathways, including cell cycle control and autophagy/apoptosis regulation, are implicated in PD neurodegeneration.
  • These findings offer promising avenues for developing novel disease-modifying therapies for Parkinson's disease.
Keywords:
Parkinson’s diseasedifferentially expressedmicroRNAneuronal survival signaling

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.8K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.2K

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
585
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.1K